Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIOGLITAZONE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where PIOGLITAZONE was used for Psoriasis.

Most Reported Side Effects for PIOGLITAZONE

Side Effect Reports % Deaths Hosp.
Bladder cancer 7,295 62.0% 1,522 103
Death 976 8.3% 976 24
Bladder transitional cell carcinoma 398 3.4% 55 16
Dyspnoea 249 2.1% 18 139
Drug ineffective 230 2.0% 2 43
Weight increased 219 1.9% 5 50
Hypoglycaemia 217 1.8% 1 133
Cardiac failure 195 1.7% 18 113
Cardiac failure congestive 194 1.7% 15 121
Drug hypersensitivity 182 1.6% 0 8
Oedema peripheral 166 1.4% 0 82
Haematuria 163 1.4% 24 25
Bladder cancer recurrent 130 1.1% 53 4
Blood glucose increased 128 1.1% 0 17
Oedema 126 1.1% 0 45

Other Indications for PIOGLITAZONE

Type 2 diabetes mellitus (8,418) Product used for unknown indication (1,487) Diabetes mellitus (914) Metastatic malignant melanoma (32) Acute myeloid leukaemia (29) Cardiovascular event prophylaxis (25) Hodgkin's disease (21) Blood glucose abnormal (20) Hyperglycaemia (17) Blood glucose increased (16)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

PIOGLITAZONE Full Profile All Psoriasis Drugs PIOGLITAZONE Demographics PIOGLITAZONE Timeline